Teva Total Stockholder Equity from 2010 to 2024
TEVA Stock | USD 16.88 0.25 1.50% |
Total Stockholder Equity | First Reported 1986-03-31 | Previous Quarter 7.5 B | Current Value 7.3 B | Quarterly Volatility 9.7 B |
Check Teva Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Teva Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 667.3 M, Interest Expense of 1.1 B or Total Revenue of 9.5 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0042 or PTB Ratio of 1.48. Teva financial statements analysis is a perfect complement when working with Teva Pharma Valuation or Volatility modules.
Teva | Total Stockholder Equity |
Latest Teva Pharma's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Teva Pharma Industries over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Teva Pharma's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Teva Pharma's overall financial position and show how it may be relating to other accounts over time.
Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
Timeline |
Teva Total Stockholder Equity Regression Statistics
Arithmetic Mean | 16,375,229,696 | |
Geometric Mean | 10,719,575,467 | |
Coefficient Of Variation | 55.93 | |
Mean Deviation | 7,557,252,284 | |
Median | 14,707,000,000 | |
Standard Deviation | 9,159,133,415 | |
Sample Variance | 83889724.9T | |
Range | 33.3B | |
R-Value | (0.41) | |
Mean Square Error | 75445436.5T | |
R-Squared | 0.16 | |
Significance | 0.13 | |
Slope | (831,662,436) | |
Total Sum of Squares | 1174456148.8T |
Teva Total Stockholder Equity History
About Teva Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Teva Pharma income statement, its balance sheet, and the statement of cash flows. Teva Pharma investors use historical funamental indicators, such as Teva Pharma's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Teva Pharma investors may use each financial statement separately, they are all related. The changes in Teva Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Teva Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Teva Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Teva Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Stockholder Equity | 7.5 B | 9.9 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.COST | Costco Wholesale Corp | |
AMZN | Amazon Inc | |
AVGO | Broadcom |
Additional Information and Resources on Investing in Teva Stock
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:Check out the analysis of Teva Pharma Correlation against competitors. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.42) | Revenue Per Share 14.277 | Quarterly Revenue Growth 0.043 | Return On Assets 0.0484 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.